Hưng Huỳnh Vĩnh Lý

Hưng Huỳnh Vĩnh Lý

Faculty of Medicine, Can Tho University of Medicine and Pharmacy, Cần Thơ, Vietnam
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2024 in Journal of Surgical Case Reports
Verified
Journal Article
Open access
PDF file
NPNang Van Pham
Nang Van Pham
DMDoi Van Mai
Doi Van Mai
PDPhu Diep Thien Duong
Phu Diep Thien Duong
HLHuan Hoang Lam
Huan Hoang Lam
Hưng Huỳnh Vĩnh LýHưng Huỳnh Vĩnh Lý
Hưng Huỳnh Vĩnh Lý
LNLuan Van Nguyen
Luan Van Nguyen
Duplication cysts are rare congenital abnormalities of the alimentary tract, typically manifesting symptoms in the first 2 years but uncommon in adults. Medical data on duplication cysts is scarce in Vietnam’s Mekong Delta region. These two adult cases aim to provide fundamental knowledge, clinical characteristics, diagnosis, risks, complications, surgical and observational treatment methods, and future bilateral tumor research. Case 1: A 21-year-old male with intestinal obstruction symptoms. Computed tomography (CT)-scan revealed a strangulated small bowel obstruction with ischemia. Laparotomy discovered a twisted ileal duplication cyst causing necrosis in ~30 cm of the small intestine. Case 2: A 34-year-old woman hospitalized for right lower quadrant pain. CT-scan showed a cystic structure protruding into the ascending colon lumen. She underwent a laparoscopic right hemicolectomy, and an ascending colonic cyst was found in the specimen. Conclusions: Duplication cysts are rare anomalies, especially in adults. Comprehending and acquiring knowledge ensures prompt diagnosis and appropriate treatment.

Verified
Journal Article
Open access
PDF file
NNNguyet Nguyen
Nguyet Nguyen
HDHan G. Diep
Han G. Diep
Hưng Huỳnh Vĩnh LýHưng Huỳnh Vĩnh Lý
Hưng Huỳnh Vĩnh Lý
NNNgoc Le Minh Nguyen
Ngoc Le Minh Nguyen
KTKatja Taxis
Katja Taxis
Thang NguyenThang Nguyen
Thang Nguyen
Background: Long-term adherence is crucial for optimal treatment outcomes in chronic cardiovascular diseases (CVDs), especially throughout the COVID-19 wide-spreading periods, making patients with chronic CVDs vulnerable subjects. Aim: To investigate the relationship between the characteristics, beliefs about prescribed medication, COVID-19 prevention measures, and medication adherence among patients with chronic CVDs. Methods: This is a cross-sectional study of outpatients with chronic CVDs in Southern Vietnam. The specific parts regarding the Beliefs about Medicines Questionnaires (BMQ—Specific) and the General Medication Adherence Scale (GMAS) were applied to assess the beliefs about and adherence to medication. The implementation measures to prevent COVID-19 in patients were evaluated according to the 5K message (facemask, disinfection, distance, no gathering, and health declaration) of the Vietnam Ministry of Health. A multivariable logistic regression with the Backward elimination (Wald) method was used to identify the associated factors of medication adherence. Results: A slightly higher score in BMQ-Necessity compared to BMQ-Concerns was observed. A total of 40.7% of patients were recorded as having not adhered to their medications. Patients’ behavior was most frequently self-reported by explaining their non-adherence (34.7%). Statistical associations were found between rural living place, unemployment status, no or only one measure(s) of COVID-19 prevention application, and medication adherence. Conclusion: During the COVID-19 spreading stage, patients generally showed a positive belief about medication when they rated the importance of taking it higher than its side effects. The data analysis suggested that rather than patients’ beliefs, the clinicians should consider the patient factors, including living place, employment, and the number of epidemic preventive measures applied for guiding the target patients for improving medication adherence.

Verified
Journal Article
Open access
PDF file
PKPham Hoang Khanh
Pham Hoang Khanh
NTNhung Thi Cam Tran
Nhung Thi Cam Tran
HTHung Do Tran
Hung Do Tran
Hưng Huỳnh Vĩnh LýHưng Huỳnh Vĩnh Lý
Hưng Huỳnh Vĩnh Lý
VTVan De Tran
Van De Tran
KNKien Nguyen
Kien Nguyen
Background: In 2018, GOLD addressed the issues of genotypes associated with risk factors for COPD. The genome-wide association study (GWAS) demonstrated an association between COPD and several genetic variants of single nucleotide polymorphisms (SNPs) of the FAM13A gene with the risk of COPD. Objective: To study the single nucleotide polymorphisms rs2869967 and rs17014601 of the FAM13A gene in chronic obstructive pulmonary disease. Subjects and research methods: 80 subjects diagnosed with COPD and 80 subjects determined not to have COPD according to GOLD 2020 criteria; the subjects were clinically examined, interviewed, and identified as possessing single nucleotide polymorphisms using the sanger sequencing method on whole blood samples. Results: The male/female ratio of the patient group and the control group was 79/1 and 39/1, respectively. The percentages of C and T alleles of rs2869967 in COPD patients were 50.6% and 49.4%, respectively. The percentages of C and T alleles of rs17014601 in COPD patients were 31.9% and 68.1%, respectively. At rs17014601, the ratio values of alleles T and C in the disease group and the control group were markedly different, making them statistically reliable (p = 0.031). The rate of CT genotype in the group of patients was considerably higher than that of the control group. The TT homozygous genotype had a lower risk of COPD compared with the other genotypes in the dominant model (ORTT/(CC + CT) = 0.441; CI95% = 0.233–0.833); this difference was statistically significant (p = 0.012). Conclusions: With rs17014601, it is characteristic that the frequency of the T allele appears more than the C allele, and the CT heterozygous phenotype accounts for the highest proportion in rs17014601 and rs2869967 recorded in COPD patients. There is an association between the genetic variant of the SNP FAM13A-rs17014601 and the risk of COPD.

1 November 2023 in Clinical, Cosmetic and Investigational Dermatology
Verified
Journal Article
Open access
PDF file
LNLam Van Nguyen
Lam Van Nguyen
HLHuy Quang Ly
Huy Quang Ly
HVHau Thi Vo
Hau Thi Vo
TPThao Thanh Pham
Thao Thanh Pham
NNNam Ky Nguyen
Nam Ky Nguyen
HMHa Thi Thao Mai
Ha Thi Thao Mai
Background: Excessive scarring is a common problem that can have significant cosmetic and psychological consequences for patients. Intralesional injection therapy, such as the use of triamcinolone, has emerged as an effective treatment option for hypertrophic scars. The objective of this study was to describe the morphological features of hypertrophic scars, categorize them, and evaluate the efficacy of triamcinolone injection therapy in treating these scars. Materials and Methods: A cross-sectional descriptive study of 80 patients with hypertrophic scars treated with triamcinolone intralesional injection at Can Tho University of Medicine and Pharmacy Hospital from 5/2018 to 5/2021. Results: There were 80 patients in all, with a male/female ratio of 1/1.05 and a median age of 15– 35. There were 129 scars in all, with scar age > 1 year accounting for 83%, keloid scars accounting for 64%, and hypertrophic scars accounting for the remaining 36%. Scars are most commonly seen on the trunk, accounting for 53.5% of all scars, particularly on the anterior chest wall. When the source of scars was discovered, trauma and acne accounted for 24% and 23%, respectively, while the rest were predominantly spontaneous scars, accounting for 49%. Scarring and discomfort of mild to moderate severity were common clinical symptoms; scars larger than 5cm in size had more symptoms than scars smaller than 5cm. Prior to the therapy, the mean Vancouver Score Scale-VSS was 6.55± 2.13. After 24 weeks of the therapy, 96.7% of patients had entirely improved itching symptoms, 75% had completely improved pain, and 25% still had minimal pain. After therapy, the mean Vancouver Score Scale-VSS was 2.55± 1.81 (p< 0.05). At week 24, 3.75% of patients experienced skin shrinkage, 3.75% experienced depigmentation, and 13.75% experienced vasodilation. Conclusion: Triamcinolone intralesional injection should be utilized as a first-line therapy for hypertrophic scarring. Plain Language Summary: This study looked at the effectiveness of triamcinolone injection (TAC) therapy in treating hypertrophic scars, which can cause significant cosmetic and psychological problems for patients. The study included 80 patients who had hypertrophic scars and were treated with triamcinolone injections over a period of 24 weeks. The majority of the scars were keloid scars (64%) and had an age of over one year (83%). Scars were most commonly found on the trunk, especially the anterior chest wall. The most common sources of scarring were trauma and acne. Mild to moderate scarring and discomfort were common symptoms, with larger scars having more symptoms. Before treatment, the mean Vancouver Score Scale-VSS was 6.55± 2.13. After 24 weeks of treatment, 96.7% of patients had improved itching symptoms, 75% had improved pain, and 25% still had minimal pain. The mean Vancouver Score Scale-VSS was also significantly reduced after treatment (2.55± 1.81). Some side effects were observed, such as skin shrinkage, depigmentation, and vasodilation, but these were experienced by a small percentage of patients. Based on these results, the study concludes that triamcinolone injection therapy should be considered as the first-line treatment for hypertrophic scarring. This therapy was found to be effective in reducing symptoms and the overall appearance of scars, with few side effects. This study provides valuable information for healthcare professionals who treat patients with hypertrophic scars, and may help improve the quality of life for those affected by this condition.

9 September 2022 in Healthcare
Verified
Journal Article
Open access
PDF file
Hưng Huỳnh Vĩnh LýHưng Huỳnh Vĩnh Lý
Hưng Huỳnh Vĩnh Lý
NLNgoc Nguyen Minh Le
Ngoc Nguyen Minh Le
Mai HaMai Ha
Mai Ha
HDHan G. Diep
Han G. Diep
ALAnh Lam
Anh Lam
Thang NguyenThang Nguyen
Thang Nguyen
(1) Background: COVID-19 has significantly affected the quality of life and the medication adherence of patients with chronic diseases. Attitudes towards the disease and preventive measures are the things that need to be considered for patient adherence to medication during the COVID-19 pandemic. We aimed to evaluate the rate and compare the medication adherence and the impact of the COVID-19 pandemic on medication adherence in Vietnamese patients with cardiovascular and endocrine–metabolic diseases. (2) Methods: A cross-sectional study was conducted on outpatients having chronic diseases such as cardiovascular or/and endocrine–metabolic diseases in some southern provinces in Vietnam. In each group of patients, medication adherence was measured and assessed with the General Medication Adherence Scale (GMAS), adjusted and validated in Vietnam. In addition, the study also investigated attitudes and practices to prevent COVID-19. (3) Results: Out of 1444 patients in our study, the level of adherence was recorded in 867 cases, accounting for 61.1%. The group of patients with only cardiovascular disease and patients with only endocrine–metabolic disease had relatively similar compliance rates of 62 and 61.1%, respectively. The leading cause of non-adherence to treatment in all three groups of patients in the study, as assessed by the GMAS, was non-adherence due to financial constraints. Our study showed that 71.6% of patients felt anxious when going to the hospital for a medical examination. However, only 53.7% identified the COVID-19 pandemic as obstructing treatment follow-up visits. The research results showed that the COVID-19 epidemic influences the patient’s psychology with regard to re-examination and treatment adherence, with p coefficients of 0.003 and <0.001, respectively. (4) Conclusion: Medication adherence rates in two disease groups are close, and financial constraint is the fundamental reason for medication non-adherence. Regulatory agencies must take care of people’s welfare to improve adherence in the epidemic context.

1 January 2025 in Current Women s Health Reviews
Verified
Journal Article
Closed access
PDF file
KPKhanh Hoang Pham
Khanh Hoang Pham
TNTin Hoang Nguyen
Tin Hoang Nguyen
TVThuc Vi
Thuc Vi
Hưng Huỳnh Vĩnh LýHưng Huỳnh Vĩnh Lý
Hưng Huỳnh Vĩnh Lý
TPThu Minh Phung
Thu Minh Phung
SCSamantha Jill Cooper
Samantha Jill Cooper
Aims: To research menstrual cycle characteristics and related factors among Vietnamese female medical students. Background: Female medical students, juggling demanding academic schedules, face the additional challenge of managing the impact of their monthly cycles on daily routines, academic achievements, and professional obligations. Objective: To investigate the factors influencing the menstrual cycle during this particularly stressful period by surveying these students. Methods: This cross-sectional study was from 3rd year of female medical students studying full-time. Results: Individuals in the severe stress group experienced irregular periods in 100% of cases. Dysmenorrhea was the next most prevalent abnormal symptom, affecting 39.7% of students. Furthermore, abdominal pain and lower back pain were the most common symptoms of premenstrual syndrome (PMS). The percentage of menorrhagia in the overweight-obesity group was almost 5 times higher than that of the other groups. Besides, central obesity increased the incidence of menorrhagia by a factor of 19. Average to high levels of physical activity can increase the risk of having dysmenorrhea. Remarkably, students who were affected by COVID-19 in terms of quality of life were also more likely to experience dysmenorrhea. Conclusion: Although most medical students had normal menstrual cycles, abdominal pain and lower back pain were the leading PMS. Moreover, overweight-obesity, central obesity, physical activity, stress, and the COVID-19 pandemic may be relative factors of the menstrual cycle.